首页|期刊导航|老年心脏病学杂志（英文版）|Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?

Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?

Yang CHEN Lu-Ying GUO Ling-Fei ZHAO Yan-Hong MA Xue-Ling ZHU Ying XU Jiang-Hua CHEN

老年心脏病学杂志（英文版）2020，Vol.17Issue(12)：782-786,5.

老年心脏病学杂志（英文版）2020，Vol.17Issue(12)：782-786,5.DOI:10.11909/j.issn.1671-5411.2020.12.002

Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?

Yang CHEN ¹Lu-Ying GUO ²Ling-Fei ZHAO ³Yan-Hong MA ⁴Xue-Ling ZHU ¹Ying XU ²Jiang-Hua CHEN³

作者信息

1. Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China
2. The Third Grade Laboratory under the National State, Administration of Traditional Chinese Medicine, Zhejiang, China
3. Key Laboratory of Kidney Disease Prevention and Control Technology, Zhejiang, China
4. National Key Clinical Department of Kidney Diseases, Institute of Nephrology, Zhejiang University, Zhejiang, China
折叠

摘要

关键词

Cardiovascular disease/Chronic kidney disease/Kidney function/Sacubitril/valsartan

Key words

Cardiovascular disease/Chronic kidney disease/Kidney function/Sacubitril/valsartan

引用本文复制引用

Yang CHEN,Lu-Ying GUO,Ling-Fei ZHAO,Yan-Hong MA,Xue-Ling ZHU,Ying XU,Jiang-Hua CHEN..Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?[J].老年心脏病学杂志（英文版）,2020,17(12):782-786,5.

基金项目

This study was supported by the National Key Research and Development Programme of China(2018YFC1314003)and the Education of Zhejiang Province(Y201328620).All authors had no conflicts of interest to disclose. （2018YFC1314003）

老年心脏病学杂志（英文版）

OACSCDSCI

ISSN：1671-5411

访问量0

下载量0

段落导航